NewLimit, a longevity startup founded by Coinbase's Brian Armstrong, raised $130 million in a Series B round, valuing the company at $810 million

The company aims to extend human life by reprogramming human genes, targeting proteins within cells to hold back aging effects, with a goal of restoring cellular function.

NewLimit has raised a total of $275 million, including $105 million from founders and $40 million in 2023, with investors including Kleiner Perkins, Khosla Ventures, and Human Capital.

NewLimit, a longevity startup founded by Coinbase's Brian Armstrong, raised $130 million in a Series B round, valuing the company at $810 million

The company aims to extend human life by reprogramming human genes, targeting proteins within cells to hold back aging effects, with a goal of restoring cellular function.

NewLimit has raised a total of $275 million, including $105 million from founders and $40 million in 2023, with investors including Kleiner Perkins, Khosla Ventures, and Human Capital.

https://www.bloomberg.com/news/articles/2025-05-06/brian-armstrong-s-human-life-extension-venture-raises-fresh-cash